US2012208783A1PendingUtilityA1

Medicine, Food And Drink Or Feed Containing Sphingomyelin

47
Assignee: KATO KENPriority: Sep 22, 2005Filed: Jan 10, 2012Published: Aug 16, 2012
Est. expirySep 22, 2025(expired)· nominal 20-yr term from priority
A61P 39/06A61P 37/08A61P 25/28A61P 31/00A61P 29/00A61P 25/00A23L 2/52A23K 50/40A61Q 19/02A61P 21/00A23V 2002/00A61Q 7/00A61K 8/68A23K 50/48A61P 17/00A61P 17/14C07F 9/10A61P 1/00A23L 33/10A61K 31/688A23K 20/158A23L 33/12A61K 35/20
47
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

It is intended to find novel pharmaceutical use of sphingomyelin and to provide preventive or therapeutic agents for various diseases as well as a food and drink product and feed comprising any of these agents. The present invention provides a pharmaceutical agent which contains sphingomyelin as an active ingredient and is any of the following agents: 1) a sialomucin secretion promoter, 2) an agent for preventing drunken sickness (hangover), 3) an antiallergic agent, 4) an antioxidant, 5) an agent for defending against infection, 6) a hair growth agent, 7) a therapeutic agent for demyelinating disease, 8) an anti-pigmentation agent, 9) an anti-inflammatory agent, and 10) an agent for improving learning ability. The present invention also provides a food and drink product or feed, characterized by comprising the agent. It is preferred that the sphingomyelin should be derived from milk.

Claims

exact text as granted — not AI-modified
1 - 3 . (canceled) 
     
     
         4 . A pharmaceutical agent which contains sphingomyelin as an active ingredient, and is an agent for improving learning ability. 
     
     
         5 . The pharmaceutical agent according to  claim 4 , wherein the sphingomyelin is derived from milk. 
     
     
         6 . A food and drink product or feed comprising the agent according to  claim 4 . 
     
     
         7 . A food and drink product or feed comprising the agent according to  claim 5 . 
     
     
         8 . A method for improving learning ability comprising administering sphingomyelin. 
     
     
         9 . The method according to  claim 8 , wherein the sphingomyelin is derived from milk. 
     
     
         10 . The method according to  claim 8 , wherein the sphingomyelin is contained as an active ingredient in a pharmaceutical agent. 
     
     
         11 . The method according to  claim 8 , wherein the sphingomyelin is formulated into one selected from the group consisting of food and drink product and feed. 
     
     
         12 . Sphingomyelin for use in improvement of learning ability. 
     
     
         13 . Sphingomyelin for use according to  claim 12 , wherein the sphingomyelin is derived from milk. 
     
     
         14 . Sphingomyelin for use according to  claim 12 , wherein the sphingomyelin is contained as an active ingredient in a pharmaceutical agent. 
     
     
         15 . Sphingomyelin for use according to  claim 12 , wherein the sphingomyelin is formulated into one selected from the group consisting of food and drink product and feed.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.